Q3 2025 Qiagen NV Earnings Call Transcript

Nov 5, 2025 / 02:30 PM GMT

Release Date Price: $46.37 (-0.25%)

Transcript

Key Points

Positve

Qiagen NV (QGEN) exceeded its targets for the third quarter, with net sales rising 6% to $533 million, surpassing the 4% constant exchange rate (CER) target.
The acquisition of Pars Biosciences expands Qiagen NV (QGEN)'s sample technologies portfolio into the fast-growing AI-driven single-cell market.
Qiagen NV (QGEN) announced a $500 million synthetic share repurchase to be completed in January 2026, contributing to a total shareholder return goal of at least $1 billion by 2028.
The company's diagnostic segment grew 11%, driven by strong instrument placements and double-digit consumable growth.
Qiagen NV (QGEN) raised its earnings target for 2025, reflecting the success of efficiency initiatives and disciplined execution despite currency headwinds and US tariffs.

Negative

The Asia-Pacific region saw a decline of 2% CER, with a mid-teen decline in China, impacting overall regional performance.
Currency movements and US tariffs created headwinds, absorbing more than 150 basis points of profitability.
The US government shutdown is expected to continue impacting sales, particularly in the academic and government sectors.
There is cautious capital spending in the life sciences sector, affecting instrument sales despite strong consumable demand.
The integration of acquisitions and currency fluctuations present ongoing challenges to achieving financial targets.

Refinitiv StreetEvents Event Transcript
P R E L I M I N A R Y V E R S I O N

QGEN.N - Qiagen NV
Q3 2025 Qiagen NV Earnings Call
Nov 05, 2025 / 02:30PM GMT

=====================
Conference Call Participants
=====================
* >>NOTE
* >>Transcription Start

=====================
Presentation
--------------------------------------------------------------------------------
>>NOTE [1]
--------------------------------------------------------------------------------

THIS TRANSCRIPT IS THE INITIAL PRELIMINARY VERSION WHICH LEVERAGES MACHINE LEARNING TECHNOLOGY. AS SUCH, PLEASE BE AWARE THERE MAY BE INACCURACIES IN THE TEXT DISPLAYED. FUTURE EDITED VERSIONS WILL BE REVIEWED FOR GREATER ACCURACY.

--------------------------------------------------------------------------------
>>Transcription Start, [2]
--------------------------------------------------------------------------------

Ladies and gentlemen, thank you for standing by. I am Katie, your Globalme call operator.

Welcome and thank you for joining Kayogen's 3rd

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.